SBOTF Stock UPDATES Stellar Biotech Inc (SBOTF) 1.8600 09/09/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Stellar Biotech Inc (SBOTF) 1.8600 $SBOTF

Stellar Biotechnologies Analyst Report; Early Mover in Fast Growing Immunotherapy Market by BrokerBank Securities, Inc.
PR Newswire - Fri Sep 05, 6:30AM CDT
Stellar Biotechnologies, Inc. (OTCQB: SBOTF) is an emerging contender in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets. KLH is both an active pharmaceutical ingredient (API) in many new immunotherapies (targeting cancer, immune disorders, and infectious diseases) as well as a finished product for measuring immune status. Stellar Biotechnologies is unique in its proprietary methods, facilities, and KLH technology.

Market Maker Surveillance Report. TCCO, BTH, PRLS, SBOTF, SGOC, INFI, Winning Stocks With Lowest Price Friction For Wednesday, September 3rd 2014
M2 - Thu Sep 04, 10:03AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4918 companies with "abnormal" market making, 2306 companies with positive Friction Factors and 2830 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Technical Communications Corp (NASDAQ:TCCO), Blyth Inc (NYSE:BTH), Peerless Systems Corp (NASDAQ RLS), STLG BIOTECH REG S (OTC:SBOTF), SOLOMON GOLD CORP (NASDAQ:SGOC), Infinity Pharmaceuticals Inc (NASDAQ:INFI). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Stellar Biotechnologies to Present at Rodman & Renshaw Global Investment Conference
Marketwire - Tue Sep 02, 11:03AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH) announced today that Frank Oakes, the Company's President and CEO, will present at the upcoming Rodman & Renshaw 2014 Global Investment Conference, on Tuesday, September 9, 2014 at 1:15PM ET.

Stellar Biotechnologies Reports on Unusual Trading Activity
Marketwire - Fri Aug 29, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH) reports that, in view of the unusual market trading activity in the Company's stock, the Investment Industry Regulatory Organization of Canada (IIROC) has contacted the Company in accordance with its usual market surveillance practice.

Stellar Biotechnologies Reports Third Quarter 2014 Financial Results and Recent Corporate Developments
Marketwire - Thu Jul 10, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), a leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets, has reported financial results for the third quarter and nine months ended May 31, 2014, and provided operational highlights.

Stellar Biotechnologies Presenting Today at 2014 TSX Venture 50(R) Spotlight Event
Marketwire - Tue Apr 01, 8:03AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), announced that the company is presenting today at the 2014 TSX Venture 50(R) Spotlight Event being held in Calgary, Canada.

Stellar Biotechnologies Presents Poster on KLH Achievements at Gordon Research Conference
Marketwire Canada - Mon Mar 03, 8:05AM CST
Stellar Biotechnologies, Inc. ("Stellar" or the "Company" (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced the presentation of a poster at the Gordon Research Conference (GRC) on Marine Natural Products, being held March 2-7, 2014 in Ventura, California.

Stellar Biotechnologies to Present at the 26th Annual ROTH Capital Growth Conference
Marketwire Canada - Thu Feb 27, 8:05AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), a company focused in the immunotherapy arena with world-leading technology in Keyhole Limpet Hemocyanin (KLH) protein, announced today that the Company will present at the 26th Annual ROTH Capital Partners Growth Conference to be held March 9-12, 2014 at The Ritz-Carlton, Laguna Niguel in Dana Point, California.

Stellar Biotechnologies Reports on Annual General and Special Meeting
Marketwire - Tue Feb 18, 8:06AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), announces that the Company held its Annual General and Special Meeting of Shareholders (the "Meeting" on Thursday, February 13, 2014 at which all Meeting resolutions were approved. The resolutions passed at the Meeting include the following:

Competitor Analysis: Clostridium Difficile Vaccines and Therapeutics
M2 - Tue Feb 18, 2:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/kkvg3x/competitor) has announced the addition of the "Competitor Analysis: Clostridium Difficile Vaccines and Therapeutics" report to their offering. Clostridium difficile infections (CDI) are a major public health concern. CDI are becoming increasingly prevalent in hospitals, long-term and primary-care facilities, primarily in patients whose normal intestinal flora have been compromised by antibiotic treatment. CDI primary virulence mechanismis the production of two toxins, TcdA and TcdB, which glucosylate Rho-family GTPases, disrupt the actin cytoskeleton, and causing cytotoxicity and inflammation. The present Competitive Intelligence Report about prophylaxis and therapy of Clostridium difficile infections provides a competitor evaluation in the field of new molecules or microorganisms for prevention or treatment of Clostridium difficle infections as of January 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report. The report includes a compilation of currently active projects in research and development of antibodies, proteins, peptides, vaccines, microorganisms and small molecules for prevention and treatment of Clostridium difficile infections. In addition, the report lists company-specific R&D pipelines of C. difficile vaccines and therapeutics. Competitor projects are listed in a tabular format providing information on: - Drug Codes, - Target / Mechanism of Action, - Class of Compound, - Company, - Product Category, - Indication, - R&D Stage and - additional comments with a hyperlink leading to the source of information. Key Topics Covered - C. difficile Vaccines - C. difficile Antibodies - C. difficile Antibiotics - C. difficile targeting Microorganisms - C. difficile Anti-Infectives - Corporate C. difficile Vaccines & Therapeutics R&D Pipelines Companies Mentioned - Actelion - AIMM Therapeutics - AmpliPhi Biosciences - Astellas Pharma - AstraZeneca (MedImmune) - Aviex Technologies - Biota Pharmaceuticals - Crestone - Cubist Pharmaceuticals - DaVolterra - Immuron - Merck - Novacta Therapeutics - Novartis - Pfizer - Prokarium - Rebiotix - Sanofi Pasteur - Seres Health - Shire (ViroPharma) - Stellar Biotechnologies - Summit - Synthetic Biologics - Valneva - VaxInnate - Venenum Biodesign For more information visit http://www.researchandmarkets.com/research/kkvg3x/competitor About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.

Stellar Biotechnologies Named 2014 TSX Venture 50(R) Company
Marketwire Canada - Thu Feb 13, 8:05AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today that the Company has been named to the 2014 TSX Venture 50(R), an exclusive ranking of the top performing companies on the TSX Venture Exchange.

Stellar Biotechnologies Presents KLH Verification Method at Aquaculture America Conference
Marketwire Canada - Wed Feb 12, 8:05AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today the presentation of a poster at Aquaculture America 2014 (Seattle, February 9-12, 2014), describing a new method for verifying authenticity of Keyhole Limpet Hemocyanin (KLH) product.

Mindoro Welcomes Significant New Investor as Prime Resources Holdings, Inc. Acquires 13.33% of Mindoro's Shares
Marketwire - Fri Jan 17, 7:01AM CST
Mindoro Resources Ltd. (TSX VENTURE: MIO)(ASX: MDO)(FRANKFURT:WKN 906167) ("Mindoro", or "the Company" is pleased to advise that Prime Resources Holdings, Inc. ("PRHI" has acquired approximately 13.33% of Mindoro's issued and outstanding common shares through a secondary trade in the market.

Stellar Biotechnologies, Inc. to Present at Two Investor Conferences in January
Marketwire - Mon Jan 06, 8:15AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH) announced today that the Company will present at two upcoming investor conferences in January: the Biotech Showcase 2014 in San Francisco and the Noble Financial Capital Markets Tenth Annual Equity Conference in South Florida.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cheyenne Real Estate: Neighborhood Nuances and Choices

Updated Category News Views 156

Unearthing the Hidden Dynamics of Cheyenne's Real Estate You've got this picturesque vision in your head of Cheyenne, Wyoming—a sprawling cowboy town with its wild winds and wide-open spaces. But if you think all those neighborhoods are cut from the same cloth, you've got another thing coming. The real estate scene here is just as varied as the prairies stretching out...

Continue Reading
NEDHSA Amplifies Tobacco-Free Push with 2026 Smokeout

Updated Category News Views 87

2026 Great American Smokeout: A Fresh Push Against Tobacco NEDHSA is sticking to its guns with a tobacco-free campaign that’s got deep roots. The 2026 Great American Smokeout, on November 19, not only highlights past efforts but looks to stir more folks into healthier habits. Beyond the campaign glitz, it’s about dragging a century-long bad habit further into the...

Continue Reading
League's AI Launch: A New Era in Healthcare

Updated Category News Views 76

AI: Healthcare's Bold New Move Ah, here we go. Another tech jump in healthcare. This time it's the folks over at League, stirring the pot with some new AI gimmicks. They've slapped together what they call an 'AI Front Door' and an 'AI Care Companion'—part of their Forge by League platform. Now, if there's one thing we know, it's that the healthcare sector loves a good...

Continue Reading
Laboratory Filtration Market Expands to $6.55B by 2031

Updated Category News Views 108

A Niche Ready to Explode The laboratory filtration market isn't exactly the sort of thing that grabs headlines in the business section, but its growth is worth giving a second look. By 2031, this market's expected to hit $6.55 billion—up from $4.49 billion in 2026. If you think that's not impressive, chew on a 7.9% CAGR for the next few years. That's like watching your...

Continue Reading
Apotex Enters U.S. Market with Axitinib Tablets Launch

Updated Category News Views 114

Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...

Continue Reading
First Time Homebuyer Tips for Southern Maryland Success

Updated Category News Views 94

Shaking Up First-Time Homebuyer Assumptions Ever hear that age-old nonsense about needing a fat stack of cash as a down payment before you can snag your first home? Yeah, turns out that's about as outdated as a rotary phone. Robin Cavallaro from RE/MAX Realty Group in Annapolis is setting the record straight for first-time buyers in Southern Maryland. Down Payment Myths...

Continue Reading
Lilly Endowment Boosts Military Families with $10M Grant

Updated Category News Views 70

A Game-Changer for Semper Fi & America's Fund Dive in, folks. What we've got here is a hefty chunk of change — $10 million to be precise — dropped into Semper Fi & America's Fund's lap by Lilly Endowment Inc. We're talking about a grant designed to shore up the long-term support system crafted for the brave souls in military families. It’s about time a significant...

Continue Reading
Silvi's Expansion Push: New Terminal in Wilmington

Updated Category News Views 113

Silvi's Latest Bet on the Southeast You know, sometimes you get a gut feeling that a company is rolling out chess moves instead of checkers. That’s what Silvi Materials is up to with their new project in Wilmington. It’s not just some fancy cement terminal—it’s a calculated expansion into the heart of the Southeast construction market. The Port of Wilmington’s...

Continue Reading
HearUSA Expands Access with AI-Powered Hearing Aids

Updated Category News Views 188

AI Revolution in Hearing Care Look, the hearing aid industry isn't known for headlines that grab you by the throat, but HearUSA just tossed a proverbial grenade into the scene with Widex Allure AI RIC. This is more than a slight tweak in hearing tech—it's a game-changer. We're talking about on-demand AI noise management blended with Widex's renowned natural sound. It's...

Continue Reading
NVCA Refreshes Key Venture Legal Documents for 2026

Updated Category News Views 77

Keeping Pace with Evolving Venture Norms Change never lets up in the fast-paced world of venture capital, does it? Just when you think you've got the rules figured out, the game shifts. This time, it's the National Venture Capital Association (NVCA) shaking things up. They've given a facelift to seven of their model legal documents, a move that reshapes the legal...

Continue Reading

Top 5 Most Recently Viewed Articles

Smart Mattress Market Expected to Reach USD 2.3 Billion Soon

Updated Category News Views 231

Overview of the Smart Mattress Market Growth Smart mattresses have emerged as key players in the bedding industry, shaped by the rising awareness of sleep's importance to overall health. With a current valuation of approximately USD 1.6 billion in 2023, the market is projected to reach USD 2.3 billion by 2032, growing at a compound annual growth rate (CAGR) of 3.7% in the...

Continue Reading
VyStar Foundation Celebrates Investment in Kennesaw State Education

Updated Category News Views 178

VyStar Credit Union and Kennesaw State Unveil VyStar Arena The anticipation surrounding the recent unveiling of VyStar Arena at Kennesaw State University is palpable, marking a significant achievement for both the university and VyStar Credit Union. This newly renovated arena will serve as the heart of athletic activities, hosting women's volleyball and men's basketball...

Continue Reading
Google Cloud and Verizon Transform Customer Engagement with AI

Updated Category News Views 599

Google Cloud and Verizon: Pioneering Customer Experience Innovations In a groundbreaking collaboration, Google Cloud has joined forces with Verizon to revolutionize customer service through innovative technology. This partnership leverages Google Cloud's generative AI to enhance the way Verizon serves its customers, resulting in significant improvements in customer...

Continue Reading
Celebrating the Holidays: Joyful Activities for Seniors

Updated Category News Views 161

Bringing Festive Cheer to Seniors This Holiday Season The holiday season is a special time for celebration, togetherness, and creating lasting memories, particularly for our seniors. Executive Home Care is dedicated to enhancing the holiday spirit for seniors by encouraging families and caregivers to engage in joyful activities that uplift and connect the loved ones in...

Continue Reading
Paragon Sports Revolution: NYC Store's Bold Overhaul

Updated Category News Views 32

Paragon Sports Redefines NYC's Retail Scene If you're thinking classic old guard can't innovate, take a gander at Paragon Sports. This 118-year-old New York cornerstone isn't just resting on its laurels as some ancient relic; they're breaking out the playbook for a fresh start in the Big Apple. In a bold move, they’ve decided to not only enhance their in-store...

Continue Reading